Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.62
+0.29 (5.44%)
At close: Mar 9, 2026, 4:00 PM EDT
5.61
-0.01 (-0.18%)
After-hours: Mar 9, 2026, 7:56 PM EDT

Immuneering Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-56.02-61.04-53.47-50.51-33.54
Upgrade
Depreciation & Amortization
0.350.390.350.80.16
Upgrade
Loss (Gain) From Sale of Assets
00.0100.01-
Upgrade
Loss (Gain) From Sale of Investments
-0.16-0.26-1.02-0.170.13
Upgrade
Stock-Based Compensation
6.316.55.734.061.8
Upgrade
Other Operating Activities
0.350.330.41--0.31
Upgrade
Change in Accounts Receivable
--0.010.230.28
Upgrade
Change in Accounts Payable
-0.4-0.11-1.111.76-0.13
Upgrade
Change in Other Net Operating Assets
4.22-0.810.12-0.280.75
Upgrade
Operating Cash Flow
-45.34-55-48.97-44.1-30.85
Upgrade
Capital Expenditures
-0.14-0.08-0.34-0.74-0.06
Upgrade
Cash Acquisitions
----0.07
Upgrade
Investment in Securities
-88.626.527.6442.57-75.63
Upgrade
Investing Cash Flow
-88.7426.437.341.83-75.62
Upgrade
Issuance of Common Stock
230.315.4328.640.3121.6
Upgrade
Other Financing Activities
-3.73-0.13-0.2-0.28-2.12
Upgrade
Financing Cash Flow
226.585.328.440.02144.26
Upgrade
Net Cash Flow
92.5-23.26-13.23-2.2537.8
Upgrade
Free Cash Flow
-45.49-55.08-49.31-44.84-30.91
Upgrade
Free Cash Flow Margin
----14148.44%-1486.17%
Upgrade
Free Cash Flow Per Share
-1.03-1.84-1.74-1.70-2.27
Upgrade
Levered Free Cash Flow
-34.36-33.65-31.1-25.99-18.59
Upgrade
Unlevered Free Cash Flow
-34.36-33.65-31.1-25.99-18.59
Upgrade
Change in Working Capital
3.82-0.93-0.971.720.9
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.